VRTX — VERTEX PHARMACEUTICALS INC
指数成分: Invesco QQQ Trust · S&P 500
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 1785 家机构在其最新 13F 申报中持有 VRTX(VERTEX PHARMACEUTICALS INC),合计申报市值 $137.65B,对应 279.19M 股。按股数计算较上季度增持 1.5%(+3.98M 股),申报市值环比上升 12.8%。持仓集中度较高:前五大持有人占申报市值的 41.6%,前十大的集中度为 56.6%。
与上一季度相比,191 家新建仓位、679 家加仓、590 家减仓、128 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
VERTEX PHARMACEUTICALS INC(VRTX)的主要机构持有人包括 Capital World Investors、Capital World Investors、BlackRock Inc,按 13F 申报市值在本页 2565 家持有人中排名居前。
VRTX 是 Invesco QQQ Trust、S&P 500 的成分股,属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 VRTX 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 VRTX 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 26.01K | $13.60M | 1.11% | 减持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 1550 | 186.13M | $97.40B | -0.4% |
| Q2 2026 | 1785 | 279.19M | $137.65B | +1.4% |
| Q1 2026 | 1718 | 275.97M | $122.42B | +1.1% |
| Q4 2025 | 1682 | 277.05M | $124.51B | +1.1% |
| Q3 2025 | 1508 | 273.76M | $105.88B | -2.9% |
| Q2 2025 | 1534 | 282.13M | $123.98B | +1.8% |
| Q1 2025 | 1562 | 277.51M | $132.89B | +2.6% |
| Q4 2024 | 1494 | 269.38M | $107.59B | +1.4% |
表内 8 个季度中,机构持股合计减少 31%(Q4 2024 → Q3 2026)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 25.97M | $13.58B | 1.66% | 减持 | |
| 23.80M | $12.44B | 0.28% | 减持 | |
| 17.81M | $9.31B | 1.34% | 减持 | |
| 16.60M | $8.68B | 0.18% | 持有 | |
| 12.02M | $6.29B | 0.19% | 增持 | |
| 8.28M | $4.33B | 0.35% | 增持 | |
| 6.08M | $3.17B | 0.17% | 增持 | |
| 5.06M | $2.65B | 0.55% | 增持 | |
| 4.94M | $2.59B | 0.12% | 增持 | |
| 4.46M | $2.45B | 0.56% | 增持 | |
| 3.62M | $1.89B | 2.46% | 减持 | |
| 3.28M | $1.71B | 0.09% | 增持 | |
| 2.56M | $1.34B | 0.76% | 增持 | |
| 1.70M | $886.45M | 0.27% | 增持 | |
| 1.69M | $885.86M | 0.77% | 减持 | |
| 1.69M | $881.47M | 0.19% | 增持 | |
| 1.54M | $805.65M | 0.04% | 增持 | |
| 1.51M | $790.67M | 0.18% | 减持 | |
| 1.43M | $748.13M | 0.16% | 持有 | |
| 1.22M | $637.47M | 0.78% | 增持 | |
| 1.20M | $632.11M | 1.07% | 增持 | |
| 1.15M | $603.47M | 0.11% | 减持 | |
| 1.05M | $548.96M | 0.13% | 减持 | |
| 886.43K | $463.45M | 0.47% | 减持 | |
| 882.82K | $461.55M | 0.20% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 6.02M 股 · $2.98B
- Sixth Street Partners Management Company, L.P. 2.04M 股 · $1.01B
- Jupiter Topco LLC 1.26M 股 · $625.80M
- National Pension Service 539.53K 股 · $268.00M
- Nykredit A/S 204.39K 股 · $101.52M
- Harvest Portfolios Group Inc. 148.19K 股 · $73.61M
- Mn Services Vermogensbeheer B.V. 74.10K 股 · $36.81M
- ADAMS DIVERSIFIED EQUITY FUND, INC. 47.30K 股 · $23.50M
- Quadrature Capital Ltd 46.95K 股 · $23.32M
- Cornerstone Advisors, LLC 24.76K 股 · $12.30M
- Saudi Central Bank 17.80K 股 · $8.84M
- ARDSLEY ADVISORY PARTNERS LP 15.00K 股 · $7.45M
完全清仓(较上季)
- STATE STREET CORP 卖出 11.73M 股 · $5.24B
- Janus Henderson Group 卖出 2.13M 股 · $951.79M
- Eversept Partners, LP 卖出 90.00K 股 · $40.19M
- Smith Group Asset Management, LLC 卖出 55.75K 股 · $24.89M
- Gradient Investments LLC 卖出 41.74K 股 · $18.64M
- CAXTON ASSOCIATES LLP 卖出 36.03K 股 · $16.09M
- ExodusPoint Capital Management, LP 卖出 22.40K 股 · $10.00M
- EXENCIAL WEALTH ADVISORS, LLC 卖出 21.60K 股 · $9.64M
- XTX Topco Ltd 卖出 15.63K 股 · $6.98M
- Trexquant Investment LP 卖出 15.17K 股 · $6.77M
- ADAR1 Capital Management, LLC 卖出 15.07K 股 · $6.73M
- SUPERSTRING CAPITAL MANAGEMENT LP 卖出 11.01K 股 · $4.92M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital World Investors | 25.97M | 26.12M | 25.37M | 25.51M | 25.91M | 28.73M | 28.53M | 28.33M | 26.81M | 26.71M | 25.57M | 21.81M | 17.98M | — | — | — | — | — | — | — |
| BlackRock Inc | 23.80M | 24.11M | 23.97M | 23.75M | 22.25M | 21.87M | 21.78M | 21.83M | 21.79M | — | — | — | — | — | — | — | — | — | — | — |
| Capital Research Global Investors | 17.81M | 19.49M | 21.13M | 17.32M | 16.55M | 16.11M | 14.54M | 10.43M | 9.00M | 8.54M | 5.74M | 3.57M | 3.37M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 16.60M | 16.58M | 16.51M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 12.02M | — | 11.73M | 11.69M | 11.61M | 11.78M | 11.79M | 11.98M | 11.82M | 11.73M | 12.01M | 12.08M | 12.04M | — | — | — | — | — | — | — |
| Invesco Ltd | 8.28M | 8.04M | 5.33M | 5.70M | 2.10M | 1.98M | 1.85M | 1.90M | 1.94M | 1.80M | 2.09M | 2.24M | 2.02M | 1.95M | 1.86M | 1.62M | 1.32M | 1.12M | 1.21M | 1.12M |
| Geode Capital Management | 6.08M | 6.02M | 6.14M | 5.98M | 5.97M | 5.93M | 5.76M | 5.65M | 5.94M | 6.33M | 5.81M | 5.67M | 5.60M | 5.54M | 5.41M | 5.38M | 5.27M | 4.53M | 4.33M | 4.36M |
| Capital International Investors | 5.06M | 4.70M | 5.13M | 4.73M | 4.69M | 2.64M | 649.90K | 342.51K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.94M | 4.88M | 5.15M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 4.46M | 3.35M | 551.13K | 550.60K | 462.95K | 523.83K | 702.03K | 760.52K | 476.83K | 552.41K | 703.06K | 672.44K | 754.52K | 831.54K | 763.91K | 791.98K | 932.85K | 990.96K | 1.12M | 1.06M |
| LOOMIS SAYLES & CO L P | 3.62M | 3.92M | 4.00M | 4.03M | 4.12M | 3.81M | 3.75M | 3.77M | 3.07M | 3.14M | 3.11M | 3.13M | 3.16M | — | — | — | — | — | — | — |
| Morgan Stanley | 3.28M | 3.24M | 3.19M | 3.12M | 3.11M | 3.33M | 3.41M | 3.17M | 3.04M | 3.26M | 3.18M | 2.98M | 2.87M | 2.78M | 2.35M | 2.58M | 1.94M | 1.83M | 825.85K | 969.81K |
| VICTORY CAPITAL MANAGEMENT INC | 2.56M | 2.17M | 1.89M | 3.36M | 2.25M | 2.16M | 293.88K | 305.15K | 310.41K | 325.75K | 407.65K | 435.84K | 578.45K | — | — | — | — | — | — | — |
| Deutsche Bank AG | 1.70M | 1.58M | 1.54M | 1.77M | 1.60M | 1.41M | 1.35M | 1.39M | 1.31M | 1.38M | 1.58M | 1.65M | 1.33M | 1.60M | 1.76M | 1.85M | 1.83M | 2.04M | 2.15M | 2.56M |
| Clearbridge Investments, LLC | 1.69M | 2.34M | 2.70M | 2.86M | 2.65M | 1.53M | 1.68M | 1.85M | 1.97M | 2.09M | 2.43M | 2.59M | 2.94M | — | — | — | — | — | — | — |
| BNY Mellon | 1.69M | 1.67M | 1.59M | 1.53M | 1.57M | 1.60M | 1.71M | 1.76M | 1.79M | 1.84M | 1.87M | 1.98M | 2.01M | 2.00M | 2.04M | 2.08M | 2.08M | 2.10M | 2.00M | 2.06M |
| Fidelity Management & Research (FMR) | 1.54M | 1.46M | 2.02M | 2.21M | 3.30M | 6.41M | 7.73M | 9.22M | 10.53M | 10.73M | 10.67M | 12.98M | 14.36M | 14.63M | 16.28M | 17.87M | 17.37M | 16.75M | 13.18M | 9.09M |
| Amundi US | 1.51M | 1.55M | 1.47M | 1.30M | 1.12M | 1.13M | 3.10M | 3.28M | 3.76M | 3.50M | 3.58M | 2.72M | 1.94M | 1.65M | 2.04M | 2.13M | 1.83M | 931.39K | 592.50K | 823.75K |
| VANGUARD FIDUCIARY TRUST CO | 1.43M | 1.43M | 1.47M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 1.22M | 759.56K | 537.25K | 832.85K | 763.70K | 242.75K | 208.14K | 839.67K | 311.64K | 96.19K | 323.09K | 296.15K | 202.23K | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold VRTX?
As of 2026-Q2, 1785 institutional funds reported holding VRTX (VERTEX PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $137.65B.
How many shares of VRTX do institutions own?
13F filers reported 279.19M shares of VRTX, worth $137.65B in aggregate at the end of 2026-Q2.
Is institutional ownership of VRTX rising or falling?
Share counts moved +1.5% versus the prior quarter — accumulation.
Who are the top institutional holders of VRTX?
The largest 13F holders are Capital World Investors, Capital World Investors, BlackRock Inc, Vanguard Group, Capital Research Global Investors; the top 25 are ranked at the top of this page.
Who are the major shareholders of VERTEX PHARMACEUTICALS INC?
The major shareholders of VERTEX PHARMACEUTICALS INC (VRTX) by reported 13F value are Capital World Investors, Capital World Investors, BlackRock Inc, Vanguard Group, Capital Research Global Investors, among 2565 institutional holders.
Which legendary investors own VRTX?
1 of the legendary investors tracked on HoldingsHub report VRTX (VERTEX PHARMACEUTICALS INC) in their latest 13F filings, led by Tweedy Browne. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on VRTX?
1 tracked superinvestors hold VRTX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.